Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 11.24% vs 6.85% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 8.29% vs 21.96% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 2.03% vs 67.27% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is 8.34% vs 23.42% in Mar 2025
Compare Profit and Loss Results of Jenburkt Pharma
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
168.00
370.00
-202.00
-54.59%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
168.00
370.00
-202.00
-54.59%
Expenditure (Ex Depriciation)
Stock Adjustments
-4.00
-6.00
2.00
33.33%
Raw Materials Consumed
37.00
170.00
-133.00
-78.24%
Power & Fuel Cost
0.00
18.00
-18.00
-100.00%
Employee Cost
49.00
60.00
-11.00
-18.33%
Operating Expenses
4.00
38.00
-34.00
-89.47%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
19.00
24.00
-5.00
-20.83%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
5.00
-5.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
125.00
340.00
-215.00
-63.24%
Operating Profit (PBDIT) excl Other Income
43.00
29.00
14.00
48.28%
Other Income
10.00
11.00
-1.00
-9.09%
Operating Profit (PBDIT)
54.00
40.00
14.00
35.00%
Interest
0.00
13.00
-13.00
-100.00%
Profit before Depriciation and Tax
53.00
27.00
26.00
96.30%
Depreciation
3.00
19.00
-16.00
-84.21%
Profit Before Taxation & Exceptional Items
50.00
8.00
42.00
525.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
46.00
8.00
38.00
475.00%
Provision for Tax
11.00
2.00
9.00
450.00%
Profit After Tax
34.00
5.00
29.00
580.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
162.00
163.00
-1.00
-0.61%
Profit Available for appropriations
197.00
169.00
28.00
16.57%
Appropriations
197.00
169.00
28.00
16.57%
Equity Dividend (%)
207%
0%
207.00
Earnings Per Share
78.71
1.22
77.49
6,351.64%
Profit And Loss - Net Sales
Net Sales 168.74 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 11.24% vs 6.85% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 43.74 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 8.29% vs 21.96% in Mar 2025
Profit And Loss - Interest
Interest 0.46 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 2.03% vs 67.27% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 34.74 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 8.34% vs 23.42% in Mar 2025
